Karl leads strategy and implementation, helping pharma and biotech clients address evolving market access challenges. With over 15 years of experience, he brings deep expertise in business development and operations in HEOR and market access consulting, commercial experience at multinational pharmaceutical and laboratory diagnostics companies, and market research expertise in nutrition, functional foods, and beverages. He held roles at AstraZeneca, LabCorp, and DSM Nutritional Products, gaining hands-on experience across development and commercialization. In consulting, Karl has led strategic initiatives at Covance and Genesis Research to support HEOR and access optimization.

He holds a BSc in Economics and an MBA in Pharmaceutical Management from Rutgers University. Karl is an active member of ISPOR and AMCP, a contributor to Patient Perspectives, and a member of No Patient Left Behind.

His expertise includes diabetes, renal disease, hyperlipidemia, beta thalassaemia, essential tremor, asthma, COPD, and multiple myeloma, with publications in real-world evidence and access strategy.